This is a regulatory disclosure intimation regarding an upcoming board meeting of Indo Us Bio Tech Limited. The meeting of the Board of Directors is scheduled to be held on Wednesday, 12th August, 2026.
The primary agenda items for the board meeting include:
- Consideration of the Unaudited Financial Results for the quarter ended on June 30, 2026 (Q1 FY27), pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
- Other corporate matters
The disclosure also confirms the continuation of the trading window closure for insiders. The trading window was previously closed effective from 1st July, 2026, as per the company's letter dated 29th June, 2026. The window shall remain closed until 48 hours after the dissemination of the unaudited Standalone financial results for the quarter ended 30th June, 2026 (both days inclusive).
The document is signed by Ms. Dimpy Joshi, Company Secretary & Compliance Officer, and was digitally signed on 4th August, 2026 at 11:28:29 +05:30.